City of Hope offers advanced cancer expertise, access to more than 700 clinical trials and international patient resources for families in Southern California and across Asia
IRVINE- Advances in cancer research, precision medicine and new therapies are creating possibilities that did not exist even a generation ago. For Chinese and Taiwanese families in Southern California and across Asia, knowing how and where to access that expertise can be an important part of navigating a cancer diagnosis.
A recent visit to City of Hope’s Los Angeles campus in Duarte by a delegation of Taiwanese technology and business leaders highlighted both the advances taking place in cancer care and resources available to international patients and families.
Led by Philip Wang, senior global advisor for the Taipei Computer Association, the delegation included representatives from ASUS, Foxconn, Elite BioMedical Corporation, Askey Computer Corporation, Richten Energy and HiPower Solution.
During a comprehensive campus tour, the delegation experienced City of Hope’s integrated approach to cancer research and treatment. As a National Cancer Institute-designated comprehensive cancer center, City of Hope brings leading physicians and scientists together with research, precision medicine, advanced genetic testing, immunotherapy and access to more than 700 clinical trials.
For eligible patients, particularly those facing difficult, rare or advanced cancers, clinical trials may provide opportunities to receive promising new therapies and treatment approaches not yet broadly available as standard care. City of Hope’s integrated model brings research, treatment and the development of innovative therapies together in one cancer-focused ecosystem, helping move scientific discoveries from the laboratory toward patients.
But advanced science was only part of what the delegation experienced.
At Hope Plaza, patients can receive treatment while looking toward the San Gabriel Mountains. Gardens and peaceful outdoor spaces are incorporated throughout the campus, and an interfaith prayer and meditation space welcomes people of different faiths and cultural backgrounds.
For Chinese and Taiwanese patients and families, City of Hope’s whole-person approach also extends to language and culture.
Arthur Yuen and Candice Zhou, senior program managers with City of Hope’s Center for International Medicine, and Roxanna Man, senior director of International Patient Services, help international patients and families navigate the journey to City of Hope, including care coordination, appointments, in-language support, pre-arrival assistance and on-site logistical coordination.
City of Hope already has an extensive international reach. Through its Center for International Medicine, City of Hope has treated patients from more than 80 countries and developed collaborations with institutions including Taipei Medical University in Taiwan, Zhejiang Provincial People’s Hospital in China and other hospitals across Asia.
For families in China, access to City of Hope expertise has also become more direct. In May 2026, City of Hope established international patient assistance offices inside United Family Hospitals (和睦家医院) in Guangzhou and Shenzhen, designed to help families connect with City of Hope expertise and receive local support while navigating potential cancer care.
Patients residing in China may also have access to City of Hope’s International Remote Second Opinion Program. The physician-to-physician service allows a patient’s local physician to consult with City of Hope specialists about the case.
The Taiwanese delegation’s visit also looked toward the future. Representatives from artificial intelligence, medical technology, software, hardware and communications explored how technology might contribute to future innovation and improve the patient experience.
For Chinese and Taiwanese families – whether in Southern California or with loved ones in Taiwan or China – these resources provide another avenue for learning about cancer expertise, clinical trials and potential treatment options.
Not every treatment or clinical trial is appropriate for every patient. But knowing that additional expertise and investigational approaches exist can give families important questions to ask and additional possibilities to explore.
For international patient information or referrals, contact City of Hope’s Center for International Medicine at +1 833-330-4673.
Mandarin- and Cantonese-speaking support is available for international patients and families at City of Hope in both Duarte and Irvine. Patients and families may also connect with Michael Chu, International Patient Services Supervisor, through WeChat or WhatsApp at +1 626-417-2498.
For families facing cancer, hope can begin with knowing where to turn.
